ReducingAgentStoichiometryCalculator

Reducing Agent Stoichiometry Calculator

api RPH Tc-99m renal imaging nuclear medicine CSV→JSON URS & FS rule-based
Open selection

Utility description: Reducing Agent Stoichiometry Calculator

Reducing Agent Stoichiometry Calculator — Calculation of optimal Tin(II) amount for Tc-99m labeling

ℹ️  Utility calculates the optimal volume of Stannous Chloride (SnCl2) solution:
    • Based on ligand mass and Tc-99m activity
    • Considering excess factor (to compensate for oxidation)
    • With checks for toxicity and colloid formation risk

⚠️  CRITICAL: Insufficient tin → low labeling efficiency!
    Excess tin → formation of Sn/Tc colloids and liver accumulation!
    Calculation helps standardize the kit preparation process.

Usage:
  ReducingAgentStoichiometryCalculator.exe                            → demo mode (console output)
  ReducingAgentStoichiometryCalculator.exe input.csv output.json      → evaluate your data

Input format:
KitName,LigandMassMg,LigandMolecularWeight,Tc99mActivityGBq,SnCl2ConcentrationMgPerML,ExcessFactor,VolumeToReconstituteML

Example:
  Tc99m-MAG3-Kit,1.0,384.4,2.0,1.0,50.0,5.0

— WHY IS THIS NEEDED?
Reduction of Technetium-99m from oxidation state +7 (pertechnetate) to lower states (+4, +5) requires a reducing agent.
Stannous Chloride (SnCl2) is the most common agent.
• Reaction stoichiometry is complex due to rapid oxidation of Sn(II) to Sn(IV) by air oxygen.
• Significant excess of Sn(II) relative to Tc-99m is required (often 1000-10000 times by moles).
• However, excess Sn(II) can lead to formation of colloidal tin hydroxide, which traps Tc-99m, creating an impurity that accumulates in liver and spleen.
• This utility helps find the balance between sufficient amount for labeling and safe levels.

⚠️  CRITICAL:
• Molar ratio Sn/Ligand must be high enough to ensure reaction kinetics.
• Sn concentration in final solution should not exceed toxicity limits (usually < 5 mcg/mL for injections, but locally higher in kits).
• SnCl2 solution must be fresh and protected from oxygen (under nitrogen).
• pH of the medium critically affects Sn(II) stability (more stable in acidic media).

Key features:
• Calculation of Tc-99m atom count based on activity (via decay constant).
• Determination of theoretical minimum tin mass.
• Application of user-defined Excess Factor.
• Colloid formation risk assessment based on final concentration.
• Support for various ligands (MAG3, DTPA, HMPAO, MDP, etc.).

Critical parameters:
• Molar ratio Sn/Ligand: > 1.0 (practically 10-100)
• Final Sn concentration: < 5.0 mg/mL (in reaction zone)
• Volume of added reductant: must be precise (microliters)

💡 Usage tips:
1. Use high-purity SnCl2 dissolved in dilute HCl to prevent hydrolysis.
2. ExcessFactor depends on kit age and vial seal integrity. Increase it for older kits.
3. If calculation shows very small volume (< 1 mkl), consider diluting the initial SnCl2 solution for better dosing accuracy.
4. Always check pH after adding reductant and ligand.
5. For high-activity preparations (> 5 GBq), increasing Sn mass may be required to prevent radiolysis.

⚠️ Note: Tc-99m labeling stoichiometry is not just chemistry, it's a race against time and radiolysis. Correct calculation of tin amount is the key to high radiochemical purity. Calculation errors lead to rejection of the entire batch of expensive isotope.

input.csv

KitName,LigandMassMg,LigandMolecularWeight,Tc99mActivityGBq,SnCl2ConcentrationMgPerML,ExcessFactor,VolumeToReconstituteML
Tc99m-MAG3-Kit,1.0,384.4,2.0,1.0,50.0,5.0
Tc99m-DTPA-Kit,2.0,393.3,3.0,0.5,100.0,10.0
Tc99m-HMPAO-Kit,0.5,350.0,1.5,2.0,20.0,5.0

URS & FS — user requirements and functional specification

URS — User Requirements Specification

  • The utility shall accept input.csv with the headers defined by the data contract.
  • Before calculation, the utility shall detect missing fields, type errors and invalid values.
  • The utility shall deterministically perform “Reducing Agent Stoichiometry Calculator”.
  • The checks shall include the following criteria: Molar ratio Sn/Ligand: > 1.0 (practically 10-100); Final Sn concentration: < 5.0 mg/mL (in reaction zone); Volume of added reductant: must be precise (microliters).
  • Each processed record shall receive a clear PASS, WARNING or FAIL status with the reason.
  • The result shall be written to output.json and retain the source values used for the checks.
  • The result supports batch-data review; release remains with authorised QA/QC personnel.

FS — Functional Specification

  1. Run ReducingAgentStoichiometryCalculator.exe in demo mode or with input.csv output.json arguments.
  2. Read UTF-8 CSV and validate the header and mandatory columns.
  3. Convert values to the expected types and validate admissibility.
  4. Perform the calculation or rule checks for “Reducing Agent Stoichiometry Calculator”.
  5. Create individual check results and the overall status.
  6. Write machine-readable JSON; invalid input shall not appear as a successful result.

input.csv example

KitName,LigandMassMg,LigandMolecularWeight,Tc99mActivityGBq,SnCl2ConcentrationMgPerML,ExcessFactor,VolumeToReconstituteML
Tc99m-MAG3-Kit,1.0,384.4,2.0,1.0,50.0,5.0

Minimum output.json structure

{
  "utility": "ReducingAgentStoichiometryCalculator",
  "source": "input.csv",
  "status": "PASS|WARNING|FAIL",
  "checks": [
    {
      "parameter": "example",
      "status": "PASS",
      "message": "criterion satisfied"
    }
  ],
  "errors": []
}

Before operational use

  • Limits and coefficients shall be approved before operational use.
  • After an executable or rule change, repeat the affected tests.
  • Retain the source CSV and JSON result together in the controlled process.

Included in packages

Radiopharmaceutical Diagnostics and Therapy QC Suite

36 utilities for clinically oriented radiopharmaceutical and workflow quality control: PET/SPECT tracers, the Tc-99m renal workflow, PRRT, PSMA therapy, targeted alpha therapy, radioembolization, bone-pain palliation, immuno-PET and generator-based radionuclide control.

Open

RPH isotope family: Tc-99m

Tc-99m radiopharmaceuticals, kit preparation, generator control, SPECT workflows and calculation utilities.

Open

RPH organ/system: bone and musculoskeletal

Bone scintigraphy, MDP/PYP, marrow, bone-pain palliation, skeletal metastases and radiosynovectomy.

Open

RPH organ/system: hepatobiliary and GI

HIDA, mebrofenin, gallbladder, gastric emptying, GI transit, bleeding and liver/spleen imaging.

Open

RPH organ/system: renal and urinary

Renography, GFR/ERPF, renal uptake, DMSA/MAG3/DTPA and bladder-related workflows.

Open

RPH Tc-99m Renal Radiopharmaceutical and Imaging QC Suite

16 utilities covering the Tc-99m renal workflow: generator eluate and Mo-99 breakthrough, Sn(II), labeling stoichiometry and pH, radiochemical purity and stability of MAG3, DTPA, DMSA(III) and glucoheptonate, gamma-camera uniformity, renal uptake and plasma clearance, bladder voiding efficiency, patient dosimetry and decay-in-storage waste management.

Open

RPH use case: Tc-99m renal and nephrourology

Renal radiopharmaceuticals and calculation workflows: MAG3, DTPA, DMSA, glucoheptonate, generator Tc-99m, dynamic renography, GFR/ERPF and dosimetry.

Open

RPH workflow: imaging QC and quantitative interpretation

Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.

Open

RPH workflow: product release QC

Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.

Open

RPH workflow: stability, storage, decay and waste

Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.

Open

RPH workflow: synthesis, labelling and kit reconstitution

Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.

Open